Novo Nordisk is using this strategy to defend and extend its obesity leadership beyond semaglutide alone
Challenges and Future Outlook for Pharma Marketers Despite the promise of DTC telehealth, challenges remain
Sweet Treats and Basic Carbs Foods such as candy, pastries, soda, and white bread flood the body with sugar
Cell type specific transcriptomic differences in depression show similar patterns between males and females but implicate distinct cell types and genes
Published clinical trials have reported large average body weight reductions in obesity protocols, dose dependent HbA1c and weight changes in type 2 diabetes protocols, and liver fat imaging endpoints in defined substudies, which is why retatrutide is now a major reference point in modern metabolic peptide research
doi: 10.3389/fped.2022.875877 Received 14 February 2022 Accepted 02 May 2022 Published 24 May 2022 Volume 10 - 2022 Edited by Arjan Te Pas, Leiden University, Netherlands Reviewed by Hans Van Rostenberghe, Universiti Sains Malaysia (USM), Malaysia